Edition:
United States

Pulse Biosciences Inc (PLSE.OQ)

PLSE.OQ on NASDAQ Stock Exchange Capital Market

14.23USD
4:00pm EDT
Change (% chg)

$-0.20 (-1.39%)
Prev Close
$14.43
Open
$14.50
Day's High
$14.96
Day's Low
$14.20
Volume
14,995
Avg. Vol
21,579
52-wk High
$34.82
52-wk Low
$12.51

Latest Key Developments (Source: Significant Developments)

Pulse Biosciences Says CEO's FY 2017 Total Compensation Was $13.6 Mln
Thursday, 12 Apr 2018 06:25am EDT 

April 12 (Reuters) - Pulse Biosciences Inc ::PULSE BIOSCIENCES SAYS CEO DARRIN UECKER'S FY 2017 TOTAL COMPENSATION WAS $13.6 MLN - SEC FILING.CEO DARRIN UECKER'S FY 2017 TOTAL COMPENSATION INCLUDES $5 MILLION IN STOCK AWARDS AND $8.2 MILLION IN OPTION AWARDS.  Full Article

Pulse Biosciences Inc Qtrly ‍Loss Per Share $0.53 ​
Friday, 16 Mar 2018 04:00pm EDT 

March 16 (Reuters) - Pulse Biosciences Inc ::PULSE BIOSCIENCES INC QTRLY ‍LOSS PER SHARE $0.53 ​.PULSE BIOSCIENCES INC - ‍2018 CASH USE IS CURRENTLY ANTICIPATED TO TOTAL $20 MILLION​.  Full Article

Pulse Biosciences announces transition of board of directors
Friday, 3 Nov 2017 08:00am EDT 

Nov 3 (Reuters) - Pulse Biosciences Inc :Pulse Biosciences announces transition of board of directors, extends appreciation to retiring members and welcomes new board members.Pulse Biosciences Inc - ‍Bob Duggan has been appointed chairman of board​.  Full Article

Pulse Biosciences announces $30 million private placement
Monday, 25 Sep 2017 08:00am EDT 

Sept 25 (Reuters) - Pulse Biosciences Inc :Pulse Biosciences announces $30 million private placement.Pulse Biosciences - ‍entered into stock purchase agreement for purchase of 2 million shares of company's common stock at a price of $15.02 per share​.  Full Article

Pulse Biosciences announces withdrawal and planned resubmission of 510(k) application for the PulseTxTM System
Monday, 11 Sep 2017 08:00am EDT 

Sept 11 (Reuters) - Pulse Biosciences Inc :Pulse Biosciences Inc - "‍remain confident" in ability to obtain a 510(k) clearance for PulseTx System and more broadly for Nano-Pulse Stimulation​.Pulse Biosciences - withdrawal was result of FDA's appropriate request for additional data that could not be provided within 90-day review period​.Pulse Biosciences Inc - ‍plans to submit supplemental information in a subsequent 510(k) application in coming months​.  Full Article

Pulse Biosciences qtrly loss per share $ 0.43
Thursday, 27 Jul 2017 04:47pm EDT 

July 27 (Reuters) - Pulse Biosciences Inc :Qtrly loss per share $ 0.43.Pulse Biosciences Inc - cash, cash equivalents, and investments totaled $15.4 million at June 30, 2017, compared to $16.4 million at December 31, 2016.  Full Article

Pulse Biosciences files for mixed shelf of up to $150 mln
Friday, 30 Jun 2017 04:59pm EDT 

June 30 (Reuters) - Pulse Biosciences Inc ::Files for mixed shelf of up to $150 million - SEC filing.  Full Article

Pulse Biosciences files for offering of 1.7 mln shares of common stock by selling stockholders
Friday, 30 Jun 2017 04:13pm EDT 

June 30 (Reuters) - Pulse Biosciences Inc :Pulse biosciences inc files for offering of 1.7 million shares of common stock by selling stockholders - sec filing.  Full Article

Pulse Biosciences Inc says qtrly loss per share $0.23 - SEC filing
Thursday, 4 May 2017 04:02pm EDT 

May 4 (Reuters) - Pulse Biosciences Inc :Says qtrly loss per share $0.23 - SEC filing.  Full Article

Pulse Biosciences says MDB Capital Group immediately waived lock-up provisions for pre-IPO stockholders
Wednesday, 19 Apr 2017 07:06am EDT 

April 19 (Reuters) - Pulse Biosciences Inc :Pulse Biosciences - on April 18, MDB Capital Group, said it immediately waived lock-up provisions for pre-IPO stockholders holding about 3.9 million shares.  Full Article

No consensus analysis data available.